Rotherham, Doncaster and South Humber NHS Foundation Trust (RDaSH) patient group direction (PGD) administration of lidocaine hydrochloride 1% injection to facilitate insertion and removal of subdermal etonogestrel (Nexplanon®) Implant in RDASH.
This patient group direction (PGD) must only be used by registered professionals who have been named and authorised by their organisation to practise under it. The most recent and in date, final signed version of the PGD must be used.
To download this PGD please follow the link: Sexual health lidocaine hydrochloride 1% injection v2.0.
To access the equality impact assessment for this policy, please see the overarching equality impact assessment.
Page last reviewed: April 30, 2024
Next review due: April 30, 2025